Rights and permissions Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s)
Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC
Clinical Outcomes Weight and glucose outcomes with both agents have been impressive, but many studies show greater weight loss and A1C reduction with Mounjaro compared with GLP-1only therapies
The controversy around Ozempic While Ozempic has made waves in the film and fashion industry for its ability to aid in weight loss, its increasing use among celebrities and influencers has raised heavy concerns
Its levels in the body may decrease by a number of factors including poor nutrition, stress and age
Clinical pharmacology biopharmaceutics review: Wegovy